Medicine 3.0: Peter Attia's Framework for Longevity

Editorial Note — Freedom of Research and the Right to Be Heard. This page documents the research, writings, and claims of Dr. Peter Attia, the Stanford-trained physician and author of Outlive: The Science and Art of Longevity, known for his framework of longevity medicine, in the spirit of open scientific inquiry. The First Amendment’s protection of speech, and the long American tradition of medical dissent that runs from Semmelweis to Barry Marshall to Linus Pauling, exists precisely so that minority and unpopular research can be examined on its merits rather than silenced by institutional consensus. We present his facts and claims as he stated them, attributed to him, drawn from his papers, book, articles and podcast. Readers are presumed to be intelligent adults capable of weighing evidence, consulting their own physicians, and making informed decisions about their own bodies. This page is provided for educational and historical-record purposes; it is not medical advice and does not endorse self-treatment. Censorship of a researcher is not refutation of the research. — MyHealthcare.com

Dr. Peter Attia is a Stanford-trained physician who spent five years in surgical training at Johns Hopkins and two years in cancer research at the National Cancer Institute before turning to longevity medicine; he is the author, with the journalist Bill Gifford, of Outlive: The Science and Art of Longevity (2023) and the host of the podcast The Drive.

This page sets out the idea at the centre of his work — what he calls “Medicine 3.0” — as he himself describes it: his three eras of medicine, his split between lifespan and healthspan, his case for starting prevention decades early, and the “marginal decade” he plans backwards from. His words are quoted only from his own published pages (his podcast show notes and his website); the full text of Outlive was not available to us, so the book is described here through its published chapter titles. Where research papers bear on the same subjects — centenarians, the biology of aging, calorie restriction and fitness — their findings are summarised neutrally as separate research, not as his claims.

Where the Medicine 3.0 Idea Appears
Medicine 1.0: Before Science
Medicine 2.0: The Scientific Method and Acute Disease
Medicine 3.0: Evidence-Informed and Early
Lifespan and Healthspan
From Fast Death to Slow Death
What Centenarians Show
The Marginal Decade and the Road Map
The Biology of Aging Behind the Framework
How He Applies the Framework
Key Research Papers
Connections

1. Where the Medicine 3.0 Idea Appears

Attia has used the phrase “Medicine 3.0” for years on his podcast and website, and it became the organising idea of his book. Outlive was published in the United States on 28 March 2023 (a 400-page hardcover from a Penguin Random House imprint) and in the United Kingdom the same year in a 482-page edition. His own website describes the book as “a new approach to preventing chronic disease and extending long-term health”.

The book’s published chapter list shows how central the idea is. Its first chapter is titled “The long game: from fast death to slow death”, and its second “Medicine 3.0: rethinking medicine for the age of chronic disease”. The third, “Objective, strategy, tactics: a road map for reading this book”, sets out how the remaining chapters are meant to be read. The British edition carries the cover line “Rethinking medicine to live better longer”.

His clearest first-hand explanation of the three eras is in an “Ask Me Anything” episode of The Drive (episode 231, released 14 November 2022), whose show notes are titled after Medicine 1.0, 2.0 and 3.0. The quotations in the next three sections come from those show notes.

Back to Table of Contents

2. Medicine 1.0: Before Science

In Attia’s scheme, the first era of medicine is the long stretch of human history before medicine had a scientific method. He describes Medicine 1.0 as the time “when we had no idea of science”. Healers in that era worked from observation, tradition and theory, but without a reliable way to test whether a treatment actually worked.

He does not present this as a period of foolishness so much as a period without tools: practitioners could notice patterns, but they had no controlled experiment to separate what helped from what merely seemed to help. In his telling, that missing tool is what divides the first era from the second.

Back to Table of Contents

3. Medicine 2.0: The Scientific Method and Acute Disease

Attia places the beginning of Medicine 2.0 with the arrival of the scientific method — he dates the change “in the late 17th century with Francis Bacon” — and says it came into its own with germ theory in the late 19th century. Once disease could be traced to specific causes, such as particular microbes, medicine could design and test treatments aimed at those causes.

In his account, Medicine 2.0 is the medicine most people know today: hospitals, antibiotics, surgery, emergency care and clinical trials. He credits it with great success against acute conditions — infections, injuries and sudden emergencies — where a problem appears, is diagnosed and is treated over days or weeks.

He also argues that this model has reached its limit. In the same episode he says Medicine 2.0 “has really peaked”, and that its strength lies mainly in acute conditions rather than in the slow, decades-long diseases that now account for most deaths in older adults. In his framing, a system built to wait for a diagnosis and then treat it arrives late to a disease that has been developing silently for twenty or thirty years.

Back to Table of Contents

4. Medicine 3.0: Evidence-Informed and Early

Attia’s third era is the one he says medicine is moving into. In the episode 231 show notes he describes Medicine 3.0 as “basically predicated on evidence informed as opposed to evidence based guidelines”. In his use, an evidence-based guideline waits until a large randomised trial has answered a question for a whole population; an evidence-informed approach draws on every kind of evidence available — trials, but also genetics, physiology, animal research and observational studies — to make a decision for one person when a definitive trial does not exist and may never be run.

The second feature he names is timing. He describes Medicine 3.0 as calling for “absurdly early preventative measures for chronic conditions” — acting years or decades before a disease would be diagnosed under the older model, because by the time chronic disease is diagnosed, in his view, much of the damage is already done.

He is explicit that this is a direction, not a finished system: “We’re not yet in medicine 3.0, but we’re in that transition.”

Across his writing the framework has a few recurring parts, which the later sections of this page follow:

Prevention comes first and starts early, rather than treatment after diagnosis.
Decisions are personalised to the individual patient’s risks, rather than set only by population averages.
The goal is not only a longer life but a better one — his split between lifespan and healthspan.
Planning works backwards from the kind of life a person wants in their final decade.

Back to Table of Contents

5. Lifespan and Healthspan

The second pillar of the framework is a definition. On his website and in the same podcast episode, Attia writes that “longevity is a balance of lifespan (living longer) and healthspan (living better).” Lifespan is simply how long a person lives. Healthspan is the stretch of those years lived in good physical, mental and emotional health.

He insists the two cannot be separated in practice. In his words: “if you want to live longer, you have to live longer without chronic disease, not live longer with chronic disease.” In his framework, adding years by keeping people alive longer once they are already ill is not the goal; the goal is to delay the illnesses themselves, so that the added years are healthy ones.

Researchers outside his practice have written about the same distinction. A 2021 review by Garmany, Yamada and Terzic in NPJ Regenerative Medicine, titled “Longevity leap: mind the healthspan gap”, describes how gains in life expectancy have outpaced gains in healthy life expectancy, leaving a growing number of years that people spend living with disease, and argues for research aimed at closing that gap.

Back to Table of Contents

6. From Fast Death to Slow Death

The title of Outlive’s first chapter, “The long game: from fast death to slow death”, sums up his reason for wanting a new kind of medicine. In earlier centuries many people died quickly — of infection, injury or childbirth — the problems Medicine 2.0 learned to treat. Today, in his account, most people in wealthy countries die slowly, of diseases that build for decades before they are diagnosed.

Attia groups those slow killers into four categories that he calls the “four horsemen” of chronic disease: atherosclerotic disease (heart disease and stroke), cancer, neurodegenerative disease such as Alzheimer’s disease, and metabolic disease, which he describes as running from high insulin levels and insulin resistance through fatty liver disease to type 2 diabetes. The book gives a chapter to each: “The ticker”, “The runaway cell”, “Chasing memory” and “The crisis of abundance”. His full account of the four is on the companion page The Four Horsemen.

Because each of these diseases develops over a long hidden period, Attia argues that they are the natural targets of Medicine 3.0: the earlier the process is caught, the more there is to gain. He has written, for example, that coronary atherosclerosis is “easily the most preventable of all the ‘four horsemen of chronic disease’” — a view set out in full on the page Apolipoprotein B and Heart Disease.

Back to Table of Contents

7. What Centenarians Show

Outlive devotes its fourth chapter to people who live to 100, under the title “Centenarians: the older you get, the healthier you have been”. The chapter title states the idea: people who reach extreme old age tend to have stayed healthy for longer, not merely to have survived disease for longer. In the Medicine 3.0 framework, centenarians are a model of what the approach aims for — a long healthspan that ends in a short period of decline.

Two studies from the New England Centenarian Study at Boston University describe this pattern, and are summarised here as research in their own right:

Survivors, delayers and escapers (2003). Evert, Lawler, Bogan and Perls examined the medical histories of centenarians and sorted them into three groups according to when the major age-related diseases appeared: “survivors”, who had been diagnosed with such a disease before age 80; “delayers”, whose first such diagnosis came at 80 or later; and “escapers”, who reached 100 without a diagnosis of the common age-related diseases studied. The paper showed that many centenarians had either delayed or escaped these diseases.
Health span approximates life span (2012). Andersen, Sebastiani, Dworkis, Feldman and Perls compared people who lived to progressively older ages, up to supercentenarians (110 and older). They reported that the older the group, the later the onset of disease and disability, so that among many of the oldest people healthspan came close to matching lifespan — a “compression of morbidity” near the limit of human life.

The terms “survivors, delayers and escapers” come from the 2003 paper; how Attia uses them within his chapter is not described here, because the book text was not available to us.

Back to Table of Contents

8. The Marginal Decade and the Road Map

A distinctive part of Attia’s framework is that he plans from the end of life backwards. In the show notes of The Drive episode 261 (10 July 2023) he defines the term: “The marginal decade is the last decade of your life” — and for most people, he says, it is “a period of poor life quality”.

His aim is to change what that final decade looks like. He asks what a person wants to be able to do in those last ten years — carry groceries, climb stairs, get up from the floor, play with grandchildren — and then works out what they would need to be capable of now, given the decline that comes with age, to still manage those tasks later. He calls the resulting list of physical goals the “Centenarian Decathlon”; his website says the book teaches “how to begin training for the ‘Centenarian Decathlon.’” The details are on the companion page Exercise, VO2 Max and the Centenarian Decathlon.

The book’s structure follows a similar logic of goal first, method second. Its third chapter is titled “Objective, strategy, tactics: a road map for reading this book”, and a later chapter, “Thinking tactically: building a framework of principles that work for you”, introduces the practical part of the book. The chapters that follow are on exercise, stability, nutrition, sleep and emotional health:

“Exercise: the most powerful longevity drug”
“Training 101: how to prepare for the centenarian decathlon”
“The gospel of stability: relearning how to move to prevent injury”
“Nutrition 3.0: you say potato, I say ‘nutritional biochemistry’” and “Putting nutritional biochemistry into practice: how to find the right eating pattern for you”
“The awakening: how to learn to love sleep, the best medicine for your brain”
“Work in progress: the high price of ignoring emotional health”

The chapter name “Nutrition 3.0” carries the same numbering into diet. His nutrition and sleep chapters are covered on the page Nutrition and Sleep in Peter Attia’s Outlive.

Back to Table of Contents

9. The Biology of Aging Behind the Framework

Medicine 3.0 rests on the view that aging itself drives the four chronic diseases, and that slowing the processes of aging could delay all of them at once. The book’s fifth chapter, “Eat less, live longer: the science of hunger and health”, takes up the research on calorie restriction and related biology. Several lines of research in this field are summarised below; they are described as the studies themselves report them, not as Attia’s statements.

The hallmarks of aging. In 2013, López-Otín, Blasco, Partridge, Serrano and Kroemer published a review in Cell that grouped the biological changes of aging into nine “hallmarks”, among them genomic instability, telomere shortening, loss of protein balance, deregulated nutrient sensing and cellular senescence. The same authors updated the scheme in 2023 to twelve hallmarks, adding disabled autophagy, chronic inflammation and changes in the gut microbial community.
Rapamycin in mice. Harrison and colleagues reported in Nature in 2009 that rapamycin, a drug that blocks the nutrient-sensing protein mammalian target of rapamycin, extended lifespan in genetically mixed mice even when feeding began late in life, at about 600 days of age. This was a study in mice, not in people.
Calorie restriction in monkeys. A Wisconsin study published in Science in 2009 (Colman and colleagues) reported that long-term calorie restriction delayed the onset of age-related disease and death in rhesus monkeys. A parallel study at the National Institute on Aging had reached a less clear result; a joint 2017 analysis by both groups (Mattison and colleagues, Nature Communications) concluded that calorie restriction improved health and survival in rhesus monkeys and attributed the differences between the two studies largely to diet composition, feeding practice and the age at which restriction began.
Calorie restriction in people. The CALERIE trial randomised healthy, non-obese adults to two years of calorie restriction or their usual diet. Exploratory results published by Kraus and colleagues in 2019 reported improvements in several cardiometabolic risk factors, including blood pressure and cholesterol measures, among those assigned to calorie restriction. The trial measured risk factors, not lifespan.
Fitness and survival. In 2018 Mandsager and colleagues followed more than 120,000 adults who had treadmill exercise tests at the Cleveland Clinic and reported that higher cardiorespiratory fitness was associated with lower long-term death from all causes, with no upper limit to the association observed. Attia draws on fitness data of this kind in his exercise material.

The site’s own pages on Caloric Restriction, Rapamycin and Senolytics cover these subjects in more depth.

Back to Table of Contents

10. How He Applies the Framework

Attia describes Medicine 3.0 not only as a theory but as the basis of his clinical work. His own website describes his current medical practice as “a medical practice that applies the principles of Medicine 3.0 to patients.” In earlier years he practised as Attia Medical, in San Diego and New York, the affiliation listed on the research papers he co-authored between 2018 and 2020.

Those papers show the framework at work in three areas:

Alzheimer’s disease prevention. He co-authored two papers with a Weill Cornell Alzheimer’s-prevention clinic describing individualised management for people at risk of Alzheimer’s dementia — a 2018 review of the mechanisms behind risk reduction and a 2019 report on individualised clinical care. Both reflect the Medicine 3.0 themes of starting early and tailoring care to the individual.
Sleep and the heart. He co-authored a 2020 study with Matthew Walker’s group at the University of California, Berkeley, titled “Broken sleep predicts hardened blood vessels”, linking fragmented sleep with calcium build-up in the arteries.
Exercise as medicine. His book calls exercise “the most powerful longevity drug” in a chapter title. On his podcast he has said that taking exercise to “a 10 out of 10” would have a “greater impact on both the length and quality of your life than any of the other domains that I can think of.”

Across these areas, the pattern he describes is the same: identify a person’s individual risks for each of the four horsemen as early as possible, act on them long before a diagnosis, and measure progress against the life the person wants to have in their final decade.

He has also said plainly that the transition is incomplete: in his own words, “We’re not yet in medicine 3.0, but we’re in that transition.”

Back to Table of Contents

Key Research Papers

Evert J, Lawler E, Bogan H, Perls T. Morbidity profiles of centenarians: survivors, delayers, and escapers. J Gerontol A Biol Sci Med Sci. 2003;58(3):232-7. — PubMed PMID: 12634289
Andersen SL, Sebastiani P, Dworkis DA, Feldman L, Perls TT. Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J Gerontol A Biol Sci Med Sci. 2012;67(4):395-405. — PubMed PMID: 22219514
Garmany A, Yamada S, Terzic A. Longevity leap: mind the healthspan gap. NPJ Regen Med. 2021;6(1):57. — PubMed PMID: 34556664
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-217. — PubMed PMID: 23746838
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278. — PubMed PMID: 36599349
Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392-5. — PubMed PMID: 19587680
Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009;325(5937):201-4. — PubMed PMID: 19590001
Mattison JA, Colman RJ, Beasley TM, Allison DB, Kemnitz JW, Roth GS, et al. Caloric restriction improves health and survival of rhesus monkeys. Nat Commun. 2017;8:14063. — PubMed PMID: 28094793
Kraus WE, Bhapkar M, Huffman KM, Pieper CF, Krupa Das S, Redman LM, et al. 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7(9):673-683. — PubMed PMID: 31303390
Mandsager K, Harb S, Cremer P, Phelan D, Nissen SE, Jaber W. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Netw Open. 2018;1(6):e183605. — PubMed PMID: 30646252
Schelke MW, Attia P, Palenchar DJ, Kaplan B, Mureb M, Ganzer CA, et al. Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer’s Disease Prevention. Front Aging Neurosci. 2018;10:96. — PubMed PMID: 29706884
Isaacson RS, Hristov H, Saif N, Hackett K, Hendrix S, Melendez J, et al. Individualized clinical management of patients at risk for Alzheimer’s dementia. Alzheimers Dement. 2019;15(12):1588-1602. — PubMed PMID: 31677936
Vallat R, Shah VD, Redline S, Attia P, Walker MP. Broken sleep predicts hardened blood vessels. PLoS Biol. 2020;18(6):e3000726. — PubMed PMID: 32497046

Medicine 3.0: Peter Attia's Framework for Longevity

Table of Contents

1. Where the Medicine 3.0 Idea Appears

2. Medicine 1.0: Before Science

3. Medicine 2.0: The Scientific Method and Acute Disease

4. Medicine 3.0: Evidence-Informed and Early

5. Lifespan and Healthspan

6. From Fast Death to Slow Death

7. What Centenarians Show

8. The Marginal Decade and the Road Map

9. The Biology of Aging Behind the Framework

10. How He Applies the Framework

Key Research Papers

PubMed Topic Searches

Further Reading

Connections